REDUCTION IN INCONTINENCE PRODUCT USE AND ASSOCIATED COST SAVINGS AFTER ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH OVERACTIVE BLADDER

被引：0
|
作者：
Schulte-Baukloh, H. [1 ]
Farrelly, E. [2 ]
Lorenzo-Gomez, M. [3 ]
Boroujerdi, A. [4 ]
Hamid, R. [5 ]
机构：
[1] Charite, Urol Practice, Berlin, Germany
[2] Sodersjukhuset Stockholm South Gen Hosp, Stockholm, Sweden
[3] Univ Salamanca, Salamanca, Spain
[4] Allergan Plc, Dublin, Ireland
[5] Univ Coll London Hosp, London, England
来源：
NEUROUROLOGY AND URODYNAMICS | 2020年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
234
引用
收藏
页码：S206 / S207
页数：2
相关论文
共 50 条
  • [1] REDUCTION IN INCONTINENCE PRODUCT USE AND ASSOCIATED COST SAVINGS AFTER ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH OVERACTIVE BLADDER
    Farrelly, Elisabeth
    Lorenzo-Gomez, Maria-Fernanda
    Hamid, Rizwan
    Boroujerdi, Amin
    Schulte-Baukloh, Heinrich
    TOXICON, 2021, 190 : S24 - S24
  • [2] REDUCTION IN INCONTINENCE PRODUCT USE AND ASSOCIATED COST SAVINGS AFTER ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH OVERACTIVE BLADDER
    Farrelly, Elisabeth
    Lorenzo-Gomez, Maria Fernanda
    Hamid, Rizwan
    Boroujerdi, Amin
    Schulte-Baukloh, Heinrich
    NEUROUROLOGY AND URODYNAMICS, 2021, 40 : S74 - S75
  • [3] REDUCTIONIN INCONTINENCE PRODUCTUSE ANDASSOCIATED COST SAVINGS AFTER ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH OVERACTIVE BLADDER
    Farrelly, Elisabeth
    Lorenzo-Gomez, Maria-Fernanda
    Hamid, Rizwan
    Boroujerdi, Amin
    Schulte-Baukloh, Heinrich
    JOURNAL OF UROLOGY, 2021, 206 : E309 - E309
  • [4] THE USE OF ONABOTULINUMTOXINA FOR TREATMENT OF OVERACTIVE BLADDER IN OLDER PATIENTS
    Sammarco, Anne
    Ferry, Elizabeth
    Patel, Dhruti
    Benchek, Penny
    Kikano, Elias
    Hijaz, Adonis
    Mahajan, Sangeeta
    JOURNAL OF UROLOGY, 2015, 193 (04): : E573 - E573
  • [5] Cost comparison of sacral nerve stimulation and OnabotulinumtoxinA to manage urinary incontinence in patients with overactive bladder
    Loveman, C. L.
    Marsh, R. M.
    Morton, R. M.
    Zeidman, R. Z.
    Ruff, L. R.
    BJU INTERNATIONAL, 2014, 113 : 49 - 49
  • [6] ONABOTULINUMTOXINA IN PATIENTS WITH OVERACTIVE BLADDER AND URINARY INCONTINENCE: CONSISTENT EFFECT OVER REPEAT TREATMENT
    Nitti, Victor W.
    Sievert, Karl-Dietrich
    Sussman, David
    Radomski, Sidney B.
    Sand, Peter
    Thompson, Catherine
    Nardo, Christopher
    Zhou, Jihao
    Globe, Denise
    Haag-Molkenteller, Cornelia
    Chapple, Christopher
    JOURNAL OF UROLOGY, 2013, 189 (04): : E559 - E560
  • [7] PREDICTORS OF ADVERSE EVENTS AFTER ONABOTULINUMTOXINA TREATMENT FOR PATIENTS WITH OVERACTIVE BLADDER SYNDROME
    Ong, H.
    Jiang, Y.
    Kuo, H.
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S112 - S113
  • [8] Intravesical Instillation of OnabotulinumtoxinA in the Treatment of Refractory Overactive Bladder in Participants with Urinary Incontinence
    Chermansky, Christopher J.
    Richter, Holly E.
    Jacoby, Karny
    Titanji, Wilson
    Jenkins, Brenda
    Geib, Till
    Brucker, Benjamin M.
    JOURNAL OF UROLOGY, 2022, 208 (04): : 855 - 862
  • [9] ONABOTULINUMTOXINA TREATMENT RESULTS IN GREATER REDUCTIONS IN URINARY INCONTINENCE IN PATIENTS WITH OVERACTIVE BLADDER COMPARED WITH SOLIFENACIN OR PLACEBO
    Herschorn, Sender
    Kohan, Alfred
    Aliotta, Philip
    McCammon, Kurt
    Sriram, Rajagopalan
    Abrams, Steve
    Lam, Wayne
    Everaert, Karel
    JOURNAL OF UROLOGY, 2016, 195 (04): : E971 - E971
  • [10] OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial
    Nitti, Victor W.
    Dmochowski, Roger
    Herschorn, Sender
    Sand, Peter
    Thompson, Catherine
    Nardo, Christopher
    Yan, Xiaohong
    Haag-Molkenteller, Cornelia
    JOURNAL OF UROLOGY, 2013, 189 (06): : 2186 - 2193
12345